Supernus Pharmaceuticals
SUPN
#4182
Rank
S$3.39 B
Marketcap
S$59.20
Share price
1.29%
Change (1 day)
19.56%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Cash on Hand

Cash on Hand as of September 2025 : S$0.36 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company has S$0.36 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Supernus Pharmaceuticals - Cash on Hand chart (from 2009 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$0.61 B83.17%
2023-12-31S$0.33 B-45.57%
2022-12-31S$0.61 B34.68%
2021-12-31S$0.45 B-17.85%
2020-12-31S$0.55 B19.46%
2019-12-31S$0.46 B-3.79%
2018-12-31S$0.48 B159.67%
2017-12-31S$0.18 B43.6%
2016-12-31S$0.13 B48.27%
2015-12-31S$87.96 M-10.44%
2014-12-31S$98.22 M-5.68%
2013-12-31S$0.10 B-3.79%
2012-12-31S$0.10 B72.17%
2011-12-31S$62.86 M49.23%
2010-12-31S$42.12 M-54.89%
2009-12-31S$93.39 M8.16%
2008-12-31S$86.34 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
S$3.58 B 884.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$12.84 B 3,425.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$21.38 B 5,769.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$10.02 B 2,650.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$24.05 B 6,501.93%๐Ÿ‡บ๐Ÿ‡ธ USA